KEMPHARM, INC 4
4 · KEMPHARM, INC · Filed Feb 16, 2016
Insider Transaction Report
Form 4
KEMPHARM, INCKMPH
Guenther Sven
Exec VP R&D
Transactions
- Award
Stock Option (right to buy)
2016-02-11+50,000→ 50,000 totalExercise: $12.62Exp: 2026-02-10→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on February 11, 2017 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer. The option expires ten years after the date of grant.